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Foot and ankle surgeons are frequently challenged by the devastating systemic consequences of diabetes
mellitus manifested through neuropathy, integumentary and joint breakdown, delayed healing, decreased
ability to fight infection, and fragile tendon/ligaments. Diabetic neuropathic pedal ulcerations lead to
amputations at an alarming rate and also carry a high mortality rate. This article will discuss causes of
diabetic pedal ulcerations that persist or recur after tendo-Achilles lengthening and will highlight areas that
need to be addressed by the practitioner such as infection, vascular and nutritional status, glucose control,
off-loading, biomechanics, and patient compliance.
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D
iabetic neuropathic pedal ulcerations lead to
amputations at an alarming rate and carry a
45%, 5-year mortality rate according to Moulik
et al. (1). The ability to efficiently and expeditiously heal
a diabetic pedal ulcer will effectively decrease the rate of
lower extremity amputations and associated morbidity.
Equinus is a well-documented biomechanical cause of
increased pedal pressures contributing to the breakdown
of friable diabetic integument (213). The treatment of
choice for gastrocnemius-soleal equinus is often a percu-
taneous tendo-Achilles lengthening (TAL). The combi-
nation of appropriate care and patient compliance will
lead to the resolution of most diabetic ulcerations.
Unfortunately, there is a small subset of patients that
despite appropriate care have pedal ulcerations that recur
or fail to resolve.
Physicians should consider previously undiagnosed
soft tissue or bone infection as the etiology of recurrent
pedal ulcerations in diabetic patients. Ulcerations of any
etiology can be complicated by skeletal, connective tissue,
or integumentary infection. Diabetic patients have an
increased risk of infection secondary to a systemic lack of
chemotaxis, phagocytosis, and intracellular bacterial
killing (5, 14). Local infection, whether associated with
soft tissue or bone, will require surgical intervention to
decrease bacterial load and decompress the area. A meta-
analysis was conducted by Dinh et al. (15) comparing the
usefulness of imaging modalities and the physical exam-
ination in accurate diagnosis of osteomyelitis. This review
included only studies that confirmed osteomyelitis with
histopathologic or microbiologic results via bone biopsy.
Bone biopsy remains the gold standard for diagnosis of
osteomyelitis. The ‘probe to bone test’ was the physical
exam technique most suggestive of osteomyelitis with a
sensitivity of .60 and specificity of .91 (15). Among
imaging modalities studied, magnetic resonance imaging
(MRI) was shown to be the most accurate with a
sensitivity of .90 and specificity of .79. The Indium-111
(IN-111) scan had sensitivity of .74 and specificity of .68.
The triphasic bone scan carried a sensitivity of .81 and
specificity of .28. From a clinical standpoint and experi-
ence, the MRI examination offers little to no definitive
evidence in differentiating the origin of bone marrow
edema as infection or neuroarthropathy (16). An original
article compared fluorodeoxyglucose positive emission
tomography (FDG PET) to MRI in diagnosing neuroar-
thropathy with or without associated infection and found
the sensitivity and accuracy to be 100 and 93.8% in FDG
PET compared to 76.9 and 75% for MRI, respectively
(17). The decrease in sensitivity and accuracy of MRI
in the setting of neuroarthopathy and suspected bone
infection is secondary to an increase in bone marrow
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subacute phases of neuroarthropathy and pedal osteo-
myelitis (17). Some authors have recommended adding
IN-111 labeled leukocyte scintigraphy to the three-phase
bone scan because of low specificity (17, 18). Studies
have shown that labeled leukocytes do accumulate in the
uninfected neurotrophic joint due in part to the hemato-
poetically active marrow. The addition of the IN-111
study has increased the specificity in detecting osteomye-
litis (18, 19). Combined IN-111 and sulfur colloid
scintigraphy is a reliable way to differentiate between
hematopoetically active marrow and infection as the
cause of leukocyte accumulation in a neuropathic joint.
This combination has been shown to be superior to three-
phase bone scintigraphy and combined IN-111/bone
scintigraphy (18, 19). While the combined IN-111 and
sulfur colloid has an accuracy of 95% in diagnosing
neuropathic joint complicated by infection, the three-
phase bone scan offers the advantage of increased
anatomic resolution (18).
The senior author recommends the three-phase bone
scan in combination with IN-111 scintigraphy (4 and
24 hr images) as well as sulfur colloid scintigraphy in
certain situations. The three-phase bone scan permits for
anatomic resolution that the other two nuclear scans
lack, thus allowing for the greatest accuracy and highest
success. Though imaging modalities are useful, bone
biopsies are suggested in recurrent ulcerations where
clinical and diagnostic testing were not diagnostic for
infection. It is our experience that bone biopsy often
reveals the presence of infection in cases of recurrent
ulcerations where all possible etiologies have been ad-
dressed. Literature has shown that a bone biopsy sent to
microbiology or histopathology carries the same sensi-
tivity for diagnosis of osteomyelitis (20). Specimens sent
to microbiology have the advantage of providing helpful
information regarding antibiotic selection. It is the
authors’ current practice to take two bone biopsies
from the area in question and send one specimen to
microbiology and one specimen to histopathology.
Diabetic patients with pedal ulcerations are often
found to have an associated ankle equinus deformity.
Ankle equinus was defined by Root et al. (21) as B10
degrees of dorsiflexion at the level of the ankle with the
knee extended and subtalar joint in neutral position . The
etiology of diabetic tendo-Achilles equinus is usually
related to a decrease in elasticity of diabetic tendons
secondary to collagen cross-linking (2224). Tensile
strength is also compromised because of collagen cross-
linking and predisposes diabetic patients to tendon
failure. Practitioners should take into consideration this
process of continued tendon glycosylation in patients
with recurrent ulcerations following an appropriate
TAL. Collagen and the non-enzymatic glycosylation of
collagen are topics of interest when discussing diabetes
and associated end-organ dysfunction. The process of
non-enzymatic reactions resulting in the formation of
complex pigments and proteinprotein cross-linking is
called glycation (22). The formation of advanced glycated
end products (AGE) is responsible for the cross-linking
of collagen. This has deleterious effects on skin, joint
mobility, wound healing, arterial elasticity, bone forma-
tion and composition, lung expansion volume, and within
the cornea (22, 23). Over time AGEs accumulate and
cause functional impairment of affected tissues as the
structural properties of collagen are altered. Glycation-
induced collagen cross-linking is strongly associated with
alterations in the biomechanical properties of tendinous
structures. These alterations lead to the loss of flexibility,
elasticity, and increased brittleness (22). Electron micro-
scopic examination of the Achilles tendon harvested from
neuropathic diabetic patients affected by neuroarthro-
pathy revealed abnormal collagen fibril morphology,
increased packing density of collagen fibrils, and de-
creased fibril diameter (22, 23). This was in direct
comparison to the Achilles tendons harvested from
diabetics not suffering from pedal neuroarthropathy.
Tendo-Achilles equinus is either secondary to collagen
cross-linking or a result of anterior leg paresis secondary
to motor neuropathy, giving a mechanical advantage to
the posterior musculature (2224). A talo-tibial exostosis
can be a cause of ankle joint pseudo-equinus and should
be ruled out in diabetic patients with a non-healing or
recurrent pedal ulceration. Gastrocnemius and gastroc-
soleal equinus are the main perpetrators of increased
pedal pressures during static and dynamic phases of gait.
The Silfverskiold test is utilized once a posterior or ankle
joint equinus has been identified and osseous ankle
equinus has been ruled out with radiological examination
(25). The TAL is often performed as an isolated or
an adjunctive procedure in the treatment of pedal ulcer-
ations associated with gastrocnemius-soleal equinus.
Those patients that are found to have isolated gastro-
cnemius equinus may benefit from a gastrocnemius
recession alone.
Mueller et al. (9, 10) described primary and secondary
benefits to a TAL procedure when B5 degrees of dorsi-
flexion is quantitatively measured in a neuropathic
diabetic patient with recurrent ulceration. The primary
benefit of the TAL with total contact casting (TCC)
compared to TCC alone is a 75% reduction in recurrent
ulceration at 8 months and 53% at 2 years (10). This
study also concluded that an acute 27% reduction in
forefoot pressures during ambulation and an obvious
increase in ankle joint dorsiflexion were two additional
secondary benefits gleaned from a TAL. This coincides
with other studies that show TCC is effective in aiding
the healing of a plantar diabetic ulceration, but fairly
ineffective in reducing the rate of recurrent ulceration (9,
10). Lin et al. (26) described 14 diabetic neuropathic
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following a TAL. A TAL reduces total plantarflexor
torque by 37% and shifts the peak torque toward
dorsiflexion. Plantarflexor torque normalizes around 8
months after the patient is no longer immobilized with-
out an associated reduction in peak torque toward
dorsiflexion. This was the first study to evaluate the
effects of a TAL prospectively and, as mentioned above,
showed there is only a temporary decrease in active and
passive plantar flexor muscle performance (9, 10). The
first reported percutaneous TAL was performed by
Delpech in 1816. In 1931 Hoke described a triple
hemisection of the Achilles tendon through one 2-cm
incision in the frontal plane with the most proximal and
distal cuts exiting posteriorly and the central cut exiting
anteriorly (27). Today the percutaneous triple hemisec-
tion is most often performed in the transverse plane,
however not without risks. Those risks most readily
identified are weak plantarflexion, neurovascular injury,
musculotendious injury, Achilles tendon rupture, and
Achilles tendon over lengthening or under lengthening (9,
28, 29). The anatomic relationships that were found to be
the most at risk were associated with cut number two (7.9
mm to sural nerve) and three (5.8 mm to FHL and 8.3 mm
to tibial nerve) (29). A study of percutaneous TAL
performed by Salamon et al. (28) on 15 cadavers,
measured the accuracy of the three cuts. Overall surgeon
accuracy was relatively high. The widths of the tendon at
the level of cuts one, two, and three from distal to
proximal were found to average 61, 50, and 55%,
respectively. This success was challenged by Hoefnagels
et al. (29). They found that one-third of their hemisections
resulted in failure to lengthen or in incomplete transec-
tion. Salamon performed the TAL in a prone position,
while most surgeons today perform this procedure as
Hoefnagels did with the patient in a supine position and
leg elevated. Patientswho have ulcers that fail to heal after
a TAL need to be assessed for a recurrent equinus
deformity secondary to either incomplete triple hemisec-
tion or continued Achilles tendon glycation. Performing
another percutaneous triple hemisection may not be the
most beneficial in these types of patients. After a
percutaneous TAL, the tendon often fibroses and with
continued glycosylation of the tendon this creates an
environment not likely to allow for sliding within the
tendon complex. The open frontal plane z-technique
for Achilles tendon lengthening will allow for avisualized
controlled lengthening of the gastrocnemius-soleal com-
plex (Fig. 1).
Nutritional status of a patient is a vital component of
wound healing that is often overlooked in the multi-
disciplinary, multifaceted approach to healing diabetic
pedal ulcerations. Malnutrition in hospitalized patients is
well documented throughout literature with rates as high
as 50%. Jensen et al. (30) showed an average incidence of
clinical and subclinical malnutrition of 42.4% in patients
undergoing orthopedic procedures. This is especially true
in surgical patients where increased stress causes protein
and energy requirements to go through a hypermetabolic
catabolic state (30). Malnutrition causes immune system
dysfunction by impairing complement activation and
production, thus decreasing the function of lymphocytes,
macrophages, and neutrophils. This impairment of
humoral and cell-mediated immunity makes the patient
Fig. 1. This picture demonstrates an open, frontal plane, Z-lengthening of the Achilles tendon. The most distal cut, to the right of the
picture, is directed anterior while the proximal cut, to the left, is directed posterior.
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of malnutrition is as important as your general physical
examination. Visceral-protein depletion can be identified
by evaluating levels of serum albumin, transferrin, or
prealbumin (5, 16). These three serum markers of protein
status have different half-lives; thus, each with their own
benefit. Serum albumin has the longest half-life of
1820 days. Hypoalbuminemia of B2.2 g/dl is a marker
of a negative catabolic state and a predictor of poor
outcome. Serum transferrin has a half-life of 89d a y s
and assesses protein status over the past 24 weeks (16).
This lab value is an accurate evaluation of nutritional
status only in lieu of normal serum iron levels. The third
screening test, prealbumin, has the shortest half-life of
23 days. Prealbumin is the least helpful in assessing
overall nutritional status. Hypoalbuminemia may adver-
sely alter wound healing by affecting intravascular
oncotic pressure and amino acid transport from the
liver. Albumin plays the role of an amino acid donor for
extra-hepatic tissue synthesis and a zinc transporter. Zinc
plays a vital role in collagen cross-linking (14, 20). A
useful adjunct to malnutrition screening is the total
number of lymphocytes per cubic millimeter, and this
speaks to a patient’s immunocompetence (14). An
‘instant nutritional assessment’ can be performed with
evaluation of albumin and lymphocytes (14). The diag-
nosis of hypoalbuminemia and lymphopenia identifies
malnourished patients with poor potential for wound
healing, impaired cellular defense, and increased suscept-
ibility to infection (30). These authors found that when
low serum albumin was noted in conjunction with
lymphopenia a fourfold increase in complications and
20-fold increase in death was seen. A mortality rate of
62% was noted in those whose albumin levels fell to 2.0 g/
dl (30). Recommendations made by Jensen and collea-
gues are that elective cases should be delayed if
serum albumin is B3.4 g/dl or the total lymphocyte
count is B1,500 cells/mm
3 (30, 31). Though not strongly
supported through literature, some vitamins and minerals
such as iron, copper, zinc, vitamin A, vitamin C, and
Fig. 2. A pre-operative clinical picture (a) showing the left foot with a large plantar ulceration after a failed tendo-Achilles lengthening
and metatarsal resection and ulcer debridement. A post-operative picture (b) showing the external ﬁxation device and local ﬂap closure
to address the skeletal deformity and large open wound. Final post-operative picture at 2-year follow-up (c).
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collagen synthesis and aid in wound healing (5). It is
the authors recommendation to assess nutritional status
via albumin, as other screening tests have many variables.
Nutritional replacement therapy can be monitored with
prealbumin as this will show level of compliance and
response to treatment.
Vascular disease in the diabetic patient is thought to
result from abnormalities of cellular signal transduction,
cell membrane fluidity, and changes in oxidative stress (5).
Nitric oxide is an important cell mediator that interferes
with monocyte and leukocyte adhesion to the endothe-
lium, platelet vessel wall interaction, smooth muscle
proliferation, and vascular tone. These processes are
paramount in the development of atherosclerosis. Dia-
betic patients often have an intrinsic dysfunction of nitric
oxide (5). Hyperglycemia impacts diabetic circulation by
decreasing sympathetic activity. This causes a decrease in
precapillary resistance and an increase in capillary flow
and pressure, resulting in capillary basement membrane
thickening (5). These changes have a deleterious effect on
autoregulation causing decrease blood flow, thus micro-
angiopathy. Decreased oxygen tension will cause wound
bed necrosis. Dying cells release endotoxins that prevent
fibroblasts and keratinocytes from reaching the wound
site. It should be common practice to perform a thorough
physical examinations on all diabetics and further assess
vascular status with non-invasive means if non-palpable
pedal pulses are encountered.
Assessments such as arterial duplex, ankle brachial
indexes, and diagnostic angiography may be warranted in
patients suspected of macrovascular compromise. Practi-
tioners should consider microvascular disease as an
etiology of recurrent ulcerations in diabetics who do not
have documented macrovascular disease. If palpable
pedal pulses are present or no macrovascular disease is
found, then further microvascular analysis should be
performed through transcutaneous partial pressure of
oxygen testing. This will assess whether or not hyperbaric
therapy will be beneficial. Practitioners may also consider
rheologic therapy to help aid in treatment of microvas-
cular disease.
Many clinical factors can be aggressively controlled.
However, the inappropriate or inadequate treatment a
patient receives at home or at a nursing facility can
be overlooked. Patient non-compliance must also be
considered. Therapies that are appropriate for a clinical
presentation may lead to failure if a patient or caregiver is
unwilling or incapable of performing the prescribed
therapy. Evaluation of a patient’s home environment
and quality of care is important to appropriately assess
physical inability or patient/care giver unwillingness to
Fig. 3. A pre-operative clinical picture (a) showing the left foot with a multiple plantar ulcerations after a failed tendo-Achilles
lengthening and ray amputation. Post-operative picture (b) showing the external ﬁxation device and soft tissue realignment procedures
to address the recurrent ulcerations. Final post-operative picture at approximately 2-year follow-up (c).
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nursing facility, evaluation of the facility compliance to
prescribed care may be warranted.
Conclusion
Diabetic patients who have recurrence of their pedal
ulceration following TAL need to be reassessed. Several
studies have noted that the strongest predictor of
complete healing of a diabetic ulceration is the 4-week
percentage change in wound area (3, 5, 8, 11). Local
wound care must be combined with adjuvant therapies to
achieve this 4-week goal. Persistent ulcerations after
surgical intervention need to be assessed for multiplanar
deformities, and if noted need to be surgically addressed.
(Figs. 2 and 3). The value of strict glucose control can
never be underestimated and should not be an under-
stated aspect of our day-to-day interactions with diabetic
patients. Foot and ankle surgeons should be advocating
strict glucose control through direct communication with
patient’s primary care physician or endocrinologist. In
our experience, a patient with glycosylated hemoglobin
of  8% and an average daily glucose of  250 mg/dl will
experience prolonged wound healing. The practitioner
should suspect previously undiagnosed or recurrent bone
or soft tissue infection, vascular compromise, non-
compliance, hypoalbuminemia, hyperglycemia, boney
prominence, and recurrence of equinus contracture when
dealing with recurrent diabetic pedal ulcerations.
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